PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.09%
Net income growth 1.25-1.5x ORCL's 8.14%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
7.81%
Some D&A expansion while ORCL is negative at -0.27%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
85.08%
Some yoy growth while ORCL is negative at -1678.57%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
6.18%
SBC growth while ORCL is negative at -10.99%. John Neff would see competitor possibly controlling share issuance more tightly.
-298.63%
Both reduce yoy usage, with ORCL at -204.96%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-141.66%
Both yoy AR lines negative, with ORCL at -117.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
242.42%
Some inventory rise while ORCL is negative at -22.78%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
98.72%
AP growth well above ORCL's 87.33%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
79.10%
Some yoy usage while ORCL is negative at -252.87%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-1945.45%
Both negative yoy, with ORCL at -5.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-22.71%
Both yoy CFO lines are negative, with ORCL at -91.45%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-4.73%
Negative yoy CapEx while ORCL is 9.59%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
82.68%
Some acquisitions while ORCL is negative at -5350.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
18.72%
Less growth in investment purchases vs. ORCL's 54.63%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-34.80%
Both yoy lines are negative, with ORCL at -86.23%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-216.42%
Both yoy lines negative, with ORCL at -86.76%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-239.86%
Both yoy lines negative, with ORCL at -90.05%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
99.28%
We repay more while ORCL is negative at -57.14%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-45.20%
Both yoy lines negative, with ORCL at -4.75%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-5.99%
We cut yoy buybacks while ORCL is 8.75%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.